Mabgeek Biotechnology

Shanghai, China · Founded 2016 · In IPO Registration

Developer of a new antibody biotechnology designed to overcome autoimmune diseases. Mabgeek Biotechnology is based in Shanghai, China and was founded in 2016. Its last reported valuation was $368 million in Jul 2025. It has raised $96.3 million.

Last reported valuation
$367.8M
Oct 2026
Priced at
—
Total raised
$96.3M
Last round
—

Who backs Mabgeek Biotechnology?

16 investors
InvestorType
Shandong Finance GroupOther
Shanghai Zhangjiang Science & Technology Venture CapitalFund of funds
DPH CapitalHedge fund
GF QianheVenture capital
Optics Valley Financial Holdings GroupOther
Zhongshan Finance InvestmentOther
Hunan Guochuang Industrial InvestmentOther
Beijing Jinhui Investment—
Guilin Sanjin Pharmaceutical Company—
Guiyang Venture Capital—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Mabgeek Biotechnology investors

16 investors are on record for Mabgeek Biotechnology, including Shandong Finance Group, Shanghai Zhangjiang Science & Technology Venture Capital, DPH Capital and GF Qianhe.

Free account
More of Mabgeek Biotechnology with a free account
  • ·The complete investor list: 16 names
  • ·Watch Mabgeek Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Mabgeek Biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View